The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Value Is Anticipated For The Live Attenuated Vaccines Market Over The Period 2026–2030?
The live attenuated vaccines market has shown robust expansion in recent years. Its size is expected to climb from $25.95 billion in 2025 to $28.52 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.9%. This historical surge can be attributed to several factors including the worldwide burden of infectious diseases, various government immunization initiatives, established childhood vaccination policies, effective hospital-based vaccine delivery, and comprehensive WHO vaccination programs.
The live attenuated vaccines market is poised for significant expansion in the coming years. It is forecasted to reach $41.11 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.6%. This expected growth throughout the forecast period stems from factors such as the demand for booster vaccinations, the threats of emerging infectious diseases, the extension of cold chain infrastructure, increased global health funding, and the advancement of next-generation vaccine platforms. Key developments anticipated during this time include the widening of national immunization programs, a growing need for pediatric vaccination, progress in vaccine stability and storage, an intensified focus on pandemic preparedness, and the innovation of multivalent vaccines.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24590&type=smp
What Underlying Factors Are Accelerating The Growth Of The Live Attenuated Vaccines Market?
The increasing spread of infectious diseases is set to boost the live attenuated vaccines market in the future. These diseases are ailments caused by detrimental microbes like bacteria, viruses, fungi, or parasites, capable of transmitting from one individual, animal, or setting to another, either directly or indirectly. Growing international travel quickens the dissemination of infectious diseases, enabling pathogens to traverse boundaries more rapidly than efforts to contain them. Live attenuated vaccines play a role in preventing infectious diseases by eliciting a robust immune response through attenuated pathogens, guaranteeing lasting immunity and lessening disease transmission. For instance, in March 2025, the World Health Organization, a Switzerland-based intergovernmental organization, reported that in 2023, approximately 10.8 million individuals contracted TB globally, comprising 6.0 million men, 3.6 million women, and 1.3 million children. Consequently, the rising occurrence of infectious diseases is fueling the expansion of the live attenuated vaccines market.
How Is The Live Attenuated Vaccines Market Divided Into Its Major Segments?
The live attenuated vaccines market covered in this report is segmented –
1) By Vaccine Type: Monovalent, Multivalent
2) By Route Of Administration: Intramuscular, Subcutaneous, Oral Attenuated, Intranasal Attenuated
3) By Indication: Influenza, Measles, Mumps and Rubella (MMR), Polio, Chickenpox, Shingles, Rotavirus, Other Indications
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
5) By End-User: Hospitals, Clinics, Diagnostic Centers, Research Institute, Other End-Users
Subsegments:
1) By Monovalent: Single-Dose Vaccines, Multiple-Dose Vaccines
2) By Multivalent: Bivalent Vaccines, Trivalent Vaccines, Quadrivalent Vaccines, Other Multivalent Vaccines
How Are Trends Transforming The Live Attenuated Vaccines Market Landscape?
Leading companies operating within the live attenuated vaccines market are focusing on developing advanced products, such as single-dose vaccines, to enhance immunization efficiency and improve patient compliance. Single-dose vaccines offer lasting immunity with just one shot, eliminating the necessity for multiple doses. This simplifies the vaccination process for both patients and healthcare providers, thereby enhancing convenience and accessibility. For instance, in November 2023, Valneva SE, a France-based biotech company specializing in vaccines for infectious diseases, announced the introduction of IXCHIQ, which secured approval from the U.S. Food and Drug Administration (FDA), a US-based health agency. This product is the world’s first live-attenuated chikungunya vaccine designated for adults aged 18 and older. The approval is significant as IXCHIQ marks the world’s inaugural licensed vaccine for chikungunya, addressing a previously unmet medical need for protection against this mosquito-borne viral disease, which can lead to severe fever, joint and muscle pain, and other symptoms.
Who Are The Prominent Organizations Shaping The Live Attenuated Vaccines Market?
Major companies operating in the live attenuated vaccines market are Merck & Co. Inc., Sanofi SA, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim International GmbH, CSL Limited, GC Biopharma, Serum Institute of India Pvt. Ltd., Bavarian Nordic, Valneva SE, Southern Research, BioFarma, Bharat Biotech International Limited, Meissa Vaccines Inc., BioDiem Ltd., Bio-Med Limited, Naobios, Lakshmi Pharmaceuticals
Read the full live attenuated vaccines market report here:
https://www.thebusinessresearchcompany.com/report/live-attenuated-vaccines-global-market-report
Which Region Is Projected To Dominate The Live Attenuated Vaccines Market During The Forecast Period?
North America was the largest region in the live attenuated vaccines market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the live attenuated vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Live Attenuated Vaccines Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=24590&type=smp
Browse Through More Reports Similar to the Global Live Attenuated Vaccines Market 2026, By The Business Research Company
Inactivated Vaccines Market Report 2026
https://www.thebusinessresearchcompany.com/report/inactivated-vaccines-global-market-report
Vaccines Market Report 2026
https://www.thebusinessresearchcompany.com/report/vaccines-global-market-report
Veterinary Vaccines Market Report 2026
https://www.thebusinessresearchcompany.com/report/veterinary-vaccines-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model